Aurinia Pharmaceuticals Inc (AUPH)

[copperpennies]

Price Targets Prior to PR

Canaccord Genuity set a $10.00 price target on shares of Aurinia Pharmaceuticals and gave the stock a “buy” rating in a research report on Friday, August 5th. Leerink Swann reaffirmed an “outperform” rating and set a $7.00 price target on shares of Aurinia Pharmaceuticals in a research report on Wednesday, July 6th. Finally, HC Wainwright assumed coverage on shares of Aurinia Pharmaceuticals in a research report on Thursday, June 30th. They set a “buy” rating and a $7.00 price target on the stock. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Aurinia Pharmaceuticals has a consensus rating of “Buy” and a consensus price target of $7.15.

Will be waiting on any PT adjustments after PR release on 8/15.

FULL ARTICLE;

http://www.americanbankingnews.com/2016/08/15/aurinia-pharmaceuticals-inc-auph-stock-rating-reaffirmed-by-fbr-co/